We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Adavosertib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01849146
Recruitment Status : Suspended (Other - Data reconciliation)
First Posted : May 8, 2013
Last Update Posted : March 15, 2018
Information provided by (Responsible Party):
National Cancer Institute (NCI)

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Suspended
  Estimated Primary Completion Date : August 15, 2018
  Study Completion Date : No date given